MedPath

MYLAN IRELAND LIMITED

🇮🇪Ireland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.mylan.ie

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

CIMA_AEMPS:14
EMA:3
NMPA:2
+1 more agencies

Drug Approvals

Revefenacin Inhalation Solution

Product Name
瑞维那新吸入溶液
Approval Number
国药准字HJ20250070
Approval Date
Jun 10, 2025
NMPA

Pretomanid Tablets

Product Name
普托马尼片
Approval Number
国药准字HJ20240153
Approval Date
Dec 1, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.